The development, manufacture and evaluation of sustained release gastric-resistant isoniazid and gastroretentive microporous rifampicin microspheres

The development, manufacture and evaluation of sustained release gastric-resistant isoniazid and gastroretentive microporous rifampicin microspheres

Expected release date-April 2020

Bibliographic Details
Main Author:	Mwila, Chiluba
Format:	Others
Language:	English
Published:	Rhodes University 2018
Online Access:	http://hdl.handle.net/10962/63497

Similar Items

Improved Stability of Rifampicin in the Presence of Gastric-Resistant Isoniazid Microspheres in Acidic Media
by: Chiluba Mwila, et al.
Published: (2020-03-01)

Study of herbal bioenhancers on various characteristics of isoniazid and rifampicin microspheres
by: P.L. Pingale, et al.
Published: (2014-04-01)

The development and assessment of sustained release nevirapine tablets
by: Mwila, Chiluba
Published: (2013)

Gastric-resistant isoniazid pellets reduced degradation of rifampicin in acidic medium
by: Fátima Duarte Freire, et al.
Published: (2014-12-01)

Development and assessment of gastroretentive sustained release captopril micro-balloons
by: Oridota, Omoyosola Omolola
Published: (2018)

Hollow microspheres for gastroretentive floating- pulsatile drug delivery: preparation and in vitro evaluation
by: Maryam Maghsoodi, et al.
Published: (2011-12-01)

Detection of MTB resistance to rifampicin and isoniazid by nitrate reductase assay
by: M. Mohiedden AbdelHaleim, et al.
Published: (2014-04-01)

Evaluation of biochip system in determining isoniazid and rifampicin resistances of mycobacterium tuberculosis in sputum samples.
by: Wei Lu, et al.
Published: (2012-01-01)

Formulation, in vitro release and transdermal diffusion of isoniazide and rifampicin for dermal tuberculosis / Reinette Benade
by: Benade, Reinette
Published: (2011)

Formulation, in vitro release and transdermal diffusion of isoniazide and rifampicin for dermal tuberculosis / Reinette Benade
by: Benade, Reinette
Published: (2011)

The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance.
by: Armand Van Deun, et al.
Published: (2020-01-01)

Susceptibility of Rifampicin-Isoniazid Resistant Mycobacterium Tuberculosis Isolates Against Levofloxacin
by: A. H. Kurniawan, et al.
Published: (2016-01-01)

Influence of isoniazid on the metabolism of rifampicin on rat hepatocytes
by: Fasich Fasich, et al.
Published: (2000-06-01)

Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
by: Gadissa Bedada Hundie, et al.
Published: (2016-01-01)

RANGES OF DRUG RESISTANCE OF THE PATHOGEN SENSITIVE TO RIFAMPICIN AND RESISTANT TO ISONIAZID IN PULMONARY TUBERCULOSIS PATIENTS
by: I. A. Burmistrova, et al.
Published: (2019-01-01)

Protects Liver From Isoniazid and Rifampicin Drug Toxicity
by: Santosh Kumar Jatav MSc, et al.
Published: (2014-07-01)

Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro
by: Ronald Anderson, et al.
Published: (2018-11-01)

Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients
by: A. K. Hemanth Kumar, et al.
Published: (2018-01-01)

Development and Evaluation of Isoniazid Loaded Silk Fibroin Microsphere
by: Narinder Singh, et al.

Correction: Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
by: Gadissa Bedada Hundie, et al.
Published: (2017-01-01)

Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?
by: Claudia M Denkinger, et al.
Published: (2014-01-01)

Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients
by: Jyoti Arora, et al.
Published: (2016-01-01)

Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates
by: M Hamze, et al.
Published: (2015-01-01)

Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates
by: Muthuraj Muthaiah, et al.
Published: (2017-08-01)

Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis
by: Soniya Sharma, et al.
Published: (2014-01-01)

MUTATIONS OF MYCOBACTERIUM TUBERCULOSIS CAUSING RESISTANCE TO RIFAMPICIN AND ISONIAZID IN THE PATIENTS WITH DIFFERENT HIV STATUS
by: E. I. Veselova, et al.
Published: (2019-02-01)

Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018
by: Zayniddin Sayfutdinov, et al.
Published: (2021-03-01)

Formulation and Evaluation of Fixed-Dose Combination of Bilayer Gastroretentive Matrix Tablet Containing Atorvastatin as Fast-Release and Atenolol as Sustained-Release
by: Sanjay Dey, et al.
Published: (2014-01-01)

Evaluation of glibenclamide microspheres for sustained release
by: Kambham Venkateswarlu
Published: (2017-04-01)

Selenium as a therapeutic adjuvant for isoniazid/rifampicin-induced hepatotoxicity
by: Elias Adikwu, et al.
Published: (2020-01-01)

Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice.
by: Yong Lian, et al.
Published: (2013-01-01)

Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles
by: Kalaiselvi Kumarasingam, et al.
Published: (2018-01-01)

Transdermal delivery of isoniazid and rifampicin by pheroid technology / Adèle Botes
by: Botes, Adèle
Published: (2009)

Transdermal delivery of isoniazid and rifampicin by pheroid technology / Adèle Botes
by: Botes, Adèle
Published: (2009)

Acquired Resistance to Isoniazid During Isoniazid Monotherapy in a Subject with Latent Infection Following Household Rifampicin-Resistant Tuberculosis Contact: A Case Report
by: Li TL, et al.
Published: (2021-04-01)

Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia*
by: Zufan Bedewi Omer, et al.
Published: (2016-01-01)

Pre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitro.
by: Indra Bergval, et al.
Published: (2012-01-01)

High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
by: Naima Fasih, et al.
Published: (2012-01-01)

Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
by: Edgar Kigozi, et al.
Published: (2018-01-01)

Evaluation of isoniazid and rifampicin on the biophysical properties of the membrane studied with 3D model systems
by: Ana Sofia Gomes Marques da Silva
Published: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dgiihoig1obr62kv47j82qvrnc